MwanzoEKSO • NASDAQ
Ekso Bionics Holdings Inc
$ 0.44
Baada ya Saa za Kazi:
$ 0.45
(2.10%)+0.0093
Imefungwa: 25 Apr, 17:58:56 GMT -4 · USD · NASDAQ · Kanusho
HisaHisa zinazouzwa MarekaniMakao yake makuu ni Marekani
Bei iliyotangulia
$ 0.43
Bei za siku
$ 0.43 - $ 0.45
Bei za mwaka
$ 0.34 - $ 1.53
Thamani ya kampuni katika soko
12.46M USD
Wastani wa hisa zilizouzwa
elfu 129.02
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
NASDAQ
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
(USD)Des 2024Mabadiliko Tangu Mwaka Uliopita
Mapato
5.09M5.01%
Matumizi ya uendeshaji wa biashara
4.94M-15.02%
Mapato halisi
-3.41M-6.19%
Kiwango cha faida halisi
-67.05-1.12%
Mapato kwa kila hisa
EBITDA
-1.83M39.28%
Asilimia ya kodi ya mapato
Jumla ya mali
Jumla ya dhima
(USD)Des 2024Mabadiliko Tangu Mwaka Uliopita
Uwekezaji wa pesa taslimu na vipindi vifupi
6.49M-24.83%
Jumla ya mali
26.65M-7.84%
Jumla ya dhima
13.94M-14.51%
Jumla ya hisa
12.71M
hisa zilizosalia
24.82M
Uwiano wa bei na thamani
0.75
Faida inayotokana na mali
-19.96%
Faida inayotokana mtaji
-27.94%
Mabadiliko halisi ya pesa taslimu
(USD)Des 2024Mabadiliko Tangu Mwaka Uliopita
Mapato halisi
-3.41M-6.19%
Pesa kutokana na shughuli
-1.43M9.53%
Pesa kutokana na uwekezaji
elfu -21.0051.16%
Pesa kutokana na ufadhili
elfu -314.00-190.23%
Mabadiliko halisi ya pesa taslimu
-1.80M-38.49%
Mtiririko huru wa pesa
elfu -204.62-58.78%
Kuhusu
Ekso Bionics Holdings Inc. is a company that develops and manufactures powered exoskeleton bionic devices that can be strapped on as wearable robots to enhance the strength, mobility, and endurance of industrial workers and people experiencing paralysis and mobility issues after a brain injury, stroke, multiple sclerosis or spinal cord injury. They enable individuals with any amount of lower extremity weakness, including those who are paralyzed, to stand up and walk. Ekso Bionics currently focuses in the health and industrial sectors. The company's first commercially available health product was called EksoGT. Ekso Bionics is the original developer of HULC, now under military development by Lockheed Martin, and the current developers of EksoNR, which allows patients who are relearning to walk the ability to stand and take steps. In December 2022, Ekso Bionics acquired the Human Motion & Control business unit from Parker Hannifin which includes the Indego product line. This acquisition allowed Ekso Bionics to begin selling exoskeletons to those who have an SCI and want a personal exoskeleton to walk at home and in their community. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
2005
Wafanyakazi
61
Gundua zaidi
Huenda unavutiwa na
Orodha hii imetokana na maudhui uliyotafuta hivi majuzi, hisa unazofuatilia na shughuli zingine. Pata maelezo zaidi

Data na maelezo yote hutolewa “kama yalivyo” kwa madhumuni ya taarifa binafsi tu, wala hayanuii kuwa ushauri wa kifedha na hayana madhumuni ya kufanya biashara au uwekezaji, kodi, kisheria, uhasibu au ushauri mwingine. Google si mshauri wa uwekezaji wala mshauri wa kifedha na haitoi maoni au mapendekezo yanayohusiana na kampuni zozote zilizojumuishwa kwenye orodha hii au hisa zozote zilizotolewa na kampuni hizo. Tafadhali wasiliana na dalali wako au mwakilishi wa kifedha ili uthibitishe bei kabla ya kufanya biashara yoyote. Pata maelezo zaidi
Watu pia hutafuta
Tafuta
Futa utafutaji
Funga kisanduku cha kutafutia
Programu za Google
Menyu kuu